Patent · US Expired

Tricyclic compounds acting at serotonin receptor subtypes

US5202318A · kind A · utility

7Cited by
5References
52Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 28, 1991
Grant dateApr 13, 1993
Priority date
Expiry dateMay 28, 2011

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/08
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds of Formula I: ##STR1## in which Z is CH.sub.2 or C.dbd.O; PA0 X and Y are independently selected from hydrogen, halogen, hydroxy, lower alkoxy, lower alkyl, nitro, amino, aminocarbonyl, (lower alkyl)amino, di(lower alkyl)amino and (lower alkanoyl)amino; and R.sup.1 is a group selected from Formulae (a), (b), (c) (d) and (e): ##STR2## in which p is 0 or 1; PA0 n is 1, 2 or 3; PA0 R.sup.2 is hydrogen, lower alkyl, C.sub.3-8 cycloalkyl, C.sub.3-8 cycloalkyl-C.sub.12 alkyl, or a group R.sup.6 -C.sub.1-2 alkyl in which R.sup.6 is thienyl, pyrrolyl or furyl optionally substituted by one or two substituents selected from lower alkyl, lower alkoxy, trifluoromethyl or halogen, or is phenyl optionally substituted by one or two substituents selected from C.sub.1-4 alkoxy, trifluoromethyl, halogen, nitro, carboxy, esterified carboxy, and C.sub.1-4 alkyl optionally further substituted by hydroxy, C.sub.1-4 alkoxy, carboxy, esterified carboxy or in vivo hydrolyzable acyloxy; PA0 each R.sup.3 is independently selected from hydrogen, hydroxy, alkyl and alkoxy; PA0 each R.sup.4 is independently hydrogen or alkyl; and PA0 R.sup.5 is hydrogen, lower alkyl, C.sub.3-8 cycloalkyl, C.sub.3-8 cy…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.